Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Shares Outstanding (Diluted Average): 2022-2025

Historic Shares Outstanding (Diluted Average) for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $1.1 million.

  • bioAffinity Technologies' Shares Outstanding (Diluted Average) rose 158.24% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 158.24%. This contributed to the annual value of $12.1 million for FY2024, which is 38.61% up from last year.
  • Per bioAffinity Technologies' latest filing, its Shares Outstanding (Diluted Average) stood at $1.1 million for Q3 2025, which was down 95.56% from $24.0 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Shares Outstanding (Diluted Average) ranged from a high of $24.0 million in Q2 2025 and a low of $412,936 during Q3 2024.
  • Over the past 3 years, bioAffinity Technologies' median Shares Outstanding (Diluted Average) value was $8.7 million (recorded in 2023), while the average stood at $10.0 million.
  • Per our database at Business Quant, bioAffinity Technologies' Shares Outstanding (Diluted Average) spiked by 216.34% in 2023 and then slumped by 95.25% in 2024.
  • bioAffinity Technologies' Shares Outstanding (Diluted Average) (Quarterly) stood at $4.5 million in 2022, then surged by 94.43% to $8.7 million in 2023, then spiked by 38.61% to $12.1 million in 2024, then skyrocketed by 158.24% to $1.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $1.1 million for Q3 2025, versus $24.0 million for Q2 2025 and $16.3 million for Q1 2025.